TMA Precision Health: Turning a Father’s Journey into a Revolution in Rare Disease Care

At TMA Precision Health, healthcare isn’t just a process, it’s a mission to bring clarity, speed, and compassion to families navigating complex medical conditions. This mission is deeply personal for Josh Resnikoff, CEO and co-founder of TMA, whose own experience as a father inspired the company’s founding.

‍

Josh’s son, Shiloh, faced a relentless cycle of unexplained fevers and uncertainty that no doctor could quickly resolve. What should have been routine care turned into a long, exhausting “diagnostic odyssey.” Frustrated by the slow, fragmented, and costly healthcare system, Josh realized there had to be a better way, one that could provide families like his with faster answers and actionable guidance.

‍

The Challenge: A Healthcare System Not Built for Complexity

Families dealing with rare diseases often face:

  • Years of waiting: Endless referrals and tests without clear results.
  • Fragmented care: Doctors working in silos, repeating procedures, and missing crucial insights.
  • Financial strain: Mounting medical bills and insurance gaps.
  • Emotional toll: Constant worry and advocacy that wears on patients and families alike.

Josh knew this broken model needed more than a patch, it needed reimagination. TMA was created to tackle the root problems of rare disease care, not just treat symptoms.

‍

Why Focus on Rare Disease?

Rare diseases may be uncommon, but they expose the biggest flaws in healthcare systems:

  • Extreme complexity: These conditions often involve multiple symptoms, advanced diagnostics, and intricate care coordination. Tackling these cases forces the creation of a robust, end-to-end platform.
  • Long diagnostic journeys: Rare diseases average seven years from symptom onset to diagnosis. TMA reduces this dramatically, initially targeting a 12-week journey for genetic epilepsy.
  • Clear impact: Faster diagnoses mean fewer unnecessary tests, fewer hospital visits, lower costs, and, most importantly, better outcomes for families.

By solving the hardest problems first, TMA built a platform capable of transforming care for all high-complexity patients.

‍

How TMA Is Changing the Game

TMA combines data, technology, and human expertise to redefine rare disease care:

  • Patient identification: Advanced analytics flag potential genetic conditions early.
  • Expert guidance: Families receive precise genetic insights and recommendations from specialists.
  • Empowering local providers: Doctors gain actionable guidance without losing their patients to distant specialists.
  • Family-first approach: Patients control their own data, and every step respects privacy and consent.

This model isn’t just about technology, it’s about human connection. AI and genomics amplify empathy, providing clarity and a path forward instead of leaving families in uncertainty.

‍

Building a Collaborative Healthcare Ecosystem

TMA works with employers, payers, providers, and pharma to create a system where everyone benefits:

  • Employers reduce costs while offering employees meaningful healthcare support.
  • Insurers avoid unnecessary spending through early, precise intervention.
  • Providers deliver high-level care locally with expert backing.
  • Patients gain faster diagnoses, actionable plans, and control over their health journey.

The result is a healthcare ecosystem that is proactive, collaborative, and centered on real human needs.

‍

Join the Movement

TMA Precision Health is more than a company, it’s a call to rewrite how healthcare works for high-complexity patients. If you’re passionate about better care, innovative solutions, or making a real difference in families’ lives, TMA invites you to learn more, get involved, and advocate for change.

‍

Visit www.tmaprecisionhealth.com to explore the science, meet the team, and discover how families across the country are getting faster answers and better outcomes.